vs
布鲁姆能源（CLNE）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是布鲁姆能源的1.8倍（$207.3M vs $112.3M），布鲁姆能源净利率更高（-38.3% vs -62.0%，领先23.7%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 2.7%），布鲁姆能源自由现金流更多（$6.5M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 4.1%）
布鲁姆能源是一家美国上市企业，设计并制造固体氧化物燃料电池，该产品可在数据中心、制造业及其他商业领域的场所内独立发电。公司成立于2001年，总部位于加利福尼亚州圣何塞，其技术依靠化学转化过程发电，无需依赖传统燃烧，可使用天然气、沼气或氢气作为燃料。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
CLNE vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $112.3M | $207.3M |
| 净利润 | $-43.0M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | -9.5% | -54.7% |
| 净利率 | -38.3% | -62.0% |
| 营收同比 | 2.7% | 25.9% |
| 净利润同比 | -42.6% | 3.5% |
| 每股收益（稀释后） | $-0.21 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $112.3M | $207.3M | ||
| Q3 25 | $106.1M | $159.9M | ||
| Q2 25 | $102.6M | $166.5M | ||
| Q1 25 | $103.8M | $139.3M | ||
| Q4 24 | $109.3M | $164.6M | ||
| Q3 24 | $104.9M | $139.5M | ||
| Q2 24 | $98.0M | $147.0M | ||
| Q1 24 | $103.7M | $108.8M |
| Q4 25 | $-43.0M | $-128.6M | ||
| Q3 25 | $-23.8M | $-180.4M | ||
| Q2 25 | $-20.2M | $-115.0M | ||
| Q1 25 | $-135.0M | $-151.1M | ||
| Q4 24 | $-30.2M | $-133.2M | ||
| Q3 24 | $-18.2M | $-133.5M | ||
| Q2 24 | $-16.3M | $-131.6M | ||
| Q1 24 | $-18.4M | $-170.7M |
| Q4 25 | -9.5% | -54.7% | ||
| Q3 25 | -12.8% | -106.9% | ||
| Q2 25 | -9.0% | -64.8% | ||
| Q1 25 | -121.7% | -102.6% | ||
| Q4 24 | -11.8% | -74.3% | ||
| Q3 24 | -8.1% | -94.6% | ||
| Q2 24 | -5.7% | -79.1% | ||
| Q1 24 | -9.0% | -151.9% |
| Q4 25 | -38.3% | -62.0% | ||
| Q3 25 | -22.4% | -112.8% | ||
| Q2 25 | -19.7% | -69.0% | ||
| Q1 25 | -130.1% | -108.5% | ||
| Q4 24 | -27.6% | -80.9% | ||
| Q3 24 | -17.3% | -95.7% | ||
| Q2 24 | -16.6% | -89.5% | ||
| Q1 24 | -17.8% | -156.8% |
| Q4 25 | $-0.21 | $-1.28 | ||
| Q3 25 | $-0.11 | $-1.81 | ||
| Q2 25 | $-0.09 | $-1.17 | ||
| Q1 25 | $-0.60 | $-1.57 | ||
| Q4 24 | $-0.14 | $-1.34 | ||
| Q3 24 | $-0.08 | $-1.40 | ||
| Q2 24 | $-0.07 | $-1.52 | ||
| Q1 24 | $-0.08 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $156.1M | $421.0M |
| 总债务越低越好 | $226.8M | — |
| 股东权益账面价值 | $559.4M | $-80.0M |
| 总资产 | $1.1B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.41× | — |
8季度趋势，按日历期对齐
| Q4 25 | $156.1M | $421.0M | ||
| Q3 25 | $232.2M | $202.5M | ||
| Q2 25 | $240.8M | $176.3M | ||
| Q1 25 | $226.6M | $127.1M | ||
| Q4 24 | $217.5M | $174.0M | ||
| Q3 24 | $243.5M | $150.6M | ||
| Q2 24 | $249.3M | $480.7M | ||
| Q1 24 | $248.9M | $112.3M |
| Q4 25 | $226.8M | — | ||
| Q3 25 | $284.3M | — | ||
| Q2 25 | $277.9M | — | ||
| Q1 25 | $271.6M | — | ||
| Q4 24 | $265.4M | — | ||
| Q3 24 | $264.1M | — | ||
| Q2 24 | $263.0M | — | ||
| Q1 24 | $262.0M | — |
| Q4 25 | $559.4M | $-80.0M | ||
| Q3 25 | $585.2M | $9.2M | ||
| Q2 25 | $590.8M | $151.3M | ||
| Q1 25 | $596.7M | $144.2M | ||
| Q4 24 | $713.3M | $255.0M | ||
| Q3 24 | $724.8M | $346.8M | ||
| Q2 24 | $723.0M | $432.4M | ||
| Q1 24 | $722.9M | $140.3M |
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.2B | $1.5B | ||
| Q3 24 | $1.2B | $1.5B | ||
| Q2 24 | $1.2B | $1.6B | ||
| Q1 24 | $1.2B | $1.3B |
| Q4 25 | 0.41× | — | ||
| Q3 25 | 0.49× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.37× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.36× | — | ||
| Q1 24 | 0.36× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $6.5M | $-100.8M |
| 自由现金流率自由现金流/营收 | 5.8% | -48.6% |
| 资本支出强度资本支出/营收 | 5.9% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $59.9M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $13.1M | $-99.8M | ||
| Q3 25 | $13.1M | $-91.4M | ||
| Q2 25 | $35.9M | $-108.3M | ||
| Q1 25 | $23.4M | $-166.5M | ||
| Q4 24 | $21.9M | $-79.3M | ||
| Q3 24 | $21.4M | $-67.0M | ||
| Q2 24 | $18.8M | $-77.0M | ||
| Q1 24 | $2.6M | $-190.7M |
| Q4 25 | $6.5M | $-100.8M | ||
| Q3 25 | $6.5M | $-92.7M | ||
| Q2 25 | $30.9M | $-110.7M | ||
| Q1 25 | $15.9M | $-167.8M | ||
| Q4 24 | $10.3M | $-79.5M | ||
| Q3 24 | $42.0K | $-68.6M | ||
| Q2 24 | $4.8M | $-79.0M | ||
| Q1 24 | $-15.6M | $-193.9M |
| Q4 25 | 5.8% | -48.6% | ||
| Q3 25 | 6.1% | -58.0% | ||
| Q2 25 | 30.2% | -66.5% | ||
| Q1 25 | 15.4% | -120.5% | ||
| Q4 24 | 9.5% | -48.3% | ||
| Q3 24 | 0.0% | -49.2% | ||
| Q2 24 | 4.9% | -53.7% | ||
| Q1 24 | -15.1% | -178.2% |
| Q4 25 | 5.9% | 0.5% | ||
| Q3 25 | 6.2% | 0.8% | ||
| Q2 25 | 4.8% | 1.5% | ||
| Q1 25 | 7.2% | 1.0% | ||
| Q4 24 | 10.5% | 0.1% | ||
| Q3 24 | 20.3% | 1.2% | ||
| Q2 24 | 14.2% | 1.4% | ||
| Q1 24 | 17.6% | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLNE
| Volume Related Fuel Sales | $73.6M | 66% |
| Services | $15.1M | 13% |
| Station Construction Sales | $10.7M | 9% |
| Volume Related Renewable Identification Number Credits | $9.5M | 8% |
| Volume Related Low Carbon Fuel Standard Credits | $3.4M | 3% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
